Literature DB >> 8560511

A prospective sero-epidemiological study of visceral leishmaniasis in Baringo District, Rift Valley Province, Kenya.

K U Schaefer1, J A Kurtzhals, G S Gachihi, A S Muller, P A Kager.   

Abstract

The incidence of visceral leishmaniasis (VL) was studied in 30 clusters with an average of 98 individuals in each cluster in a defined, endemic rural area of Baringo District, Kenya. The clusters were centred around recent cases of VL. Anti-leishmanial antibodies were measured by the direct agglutination test (DAT) and a clinical examination was performed on 2 occasions between April 1991 and May 1993. Of 2934 individuals tested by the DAT during the first visit, 78 (2.7%) were seropositive, 54 with and 24 without a history of VL. The seroconversion rate was 9/1000 person-years of observation (95% confidence interval 5.1-12.92) among 2332 seronegative individuals retested the following year. During the entire study period, VL was diagnosed in 10 patients, with an incidence rate of 2.2/1000 person-years of observation (95% confidence interval 0.8-3.6). Household contacts of individuals with previously confirmed VL had a higher frequency of DAT positivity than the rest of the population. This difference was significant for both sexes. These results suggest transmission in and around houses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560511     DOI: 10.1016/0035-9203(95)90070-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  19 in total

1.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

3.  Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis.

Authors:  Sultana S Banu; Wieland Meyer; Be-Nazir Ahmed; Rady Kim; Rogan Lee
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

4.  Risk factors of visceral leishmaniasis in East Africa: a case-control study in Pokot territory of Kenya and Uganda.

Authors:  Jan H Kolaczinski; Richard Reithinger; Dagemlidet T Worku; Andrew Ocheng; John Kasimiro; Narcis Kabatereine; Simon Brooker
Journal:  Int J Epidemiol       Date:  2008-01-09       Impact factor: 7.196

5.  Factors associated with Leishmania asymptomatic infection: results from a cross-sectional survey in highland northern Ethiopia.

Authors:  Estefanía Custodio; Endalamaw Gadisa; Luis Sordo; Israel Cruz; Javier Moreno; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Zelalem Abraham; Tsegaye Hailu; Carmen Cañavate
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

Review 6.  The AFHSC-Division of GEIS Operations Predictive Surveillance Program: a multidisciplinary approach for the early detection and response to disease outbreaks.

Authors:  Clara J Witt; Allen L Richards; Penny M Masuoka; Desmond H Foley; Anna L Buczak; Lillian A Musila; Jason H Richardson; Michelle G Colacicco-Mayhugh; Leopoldo M Rueda; Terry A Klein; Assaf Anyamba; Jennifer Small; Julie A Pavlin; Mark M Fukuda; Joel Gaydos; Kevin L Russell; Richard C Wilkerson; Robert V Gibbons; Richard G Jarman; Khin S Myint; Brian Pendergast; Sheri Lewis; Jorge E Pinzon; Kathrine Collins; Matthew Smith; Edwin Pak; Compton Tucker; Kenneth Linthicum; Todd Myers; Moustafa Mansour; Ken Earhart; Heung Chul Kim; Ju Jiang; Dave Schnabel; Jeffrey W Clark; Rosemary C Sang; Elizabeth Kioko; David C Abuom; John P Grieco; Erin E Richards; Steven Tobias; Matthew R Kasper; Joel M Montgomery; Dave Florin; Jean-Paul Chretien; Trudy L Philip
Journal:  BMC Public Health       Date:  2011-03-04       Impact factor: 3.295

7.  Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

Authors:  Bart Ostyn; Kamlesh Gidwani; Basudha Khanal; Albert Picado; François Chappuis; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

8.  Epidemiologic aspects of an emerging focus of visceral leishmaniasis in Tbilisi, Georgia.

Authors:  Ekaterina Giorgobiani; Nazibrola Chitadze; Gvantsa Chanturya; Marina Grdzelidze; Ryan C Jochim; Anna Machablishvili; Tsiuri Tushishvili; Yulia Zedginidze; Marina K Manjgaladze; Nino Iashvili; Manana P Makharadze; Tsiuri Zakaraya; Konstantin Kikaleishvili; Ivan Markhvashvili; Goderdzi Badashvili; Teymuraz Daraselia; Michael P Fay; Shaden Kamhawi; David Sacks
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

9.  Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.

Authors:  Epco Hasker; Sangeeta Kansal; Paritosh Malaviya; Kamlesh Gidwani; Albert Picado; Rudra Pratap Singh; Ankita Chourasia; Abhishek Kumar Singh; Ravi Shankar; Joris Menten; Mary Edyth Wilson; Mary Elizabeth Wilson; Marleen Boelaert; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14

10.  Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006.

Authors:  Marie-Eve Raguenaud; Anna Jansson; Veerle Vanlerberghe; Geert Van der Auwera; Stijn Deborggraeve; Jean-Claude Dujardin; Giannos Orfanos; Tony Reid; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.